May 25, 2021 | Federal Issues, Medicare Part D
By Surabhi Dangi-Garimella, PhD Opinions vary on the impact H.R.3 would have on patients and the U.S. health care system as a whole, depending on who you ask. Some of the changes proposed by H.R.3 are directed to redesign the Medicare Part D prescription drug...
Read more
Jan 20, 2021 | Featured, Medicare Part D
By Surabhi Dangi-Garimella, Ph.D. Prescription drugs can be expensive, and for patients undergoing treatment for certain chronic conditions, cost-sharing is a heavy financial burden, especially if you are a Medicare beneficiary on a fixed income. While bills...
Read more
Nov 19, 2019 | Medicare Part D, Op-Ed
By Terry Wilcox Executive Director, Patients Rising Better health care was the top concern for 41 percent of voters in the midterm elections but Congress does not have to wait until next year to pass bipartisan health legislation. Among the must-pass bills for the...
Read more
Aug 6, 2019 | Drug Costs, Medicare Part D, News
Divided government, as a result of Democrats taking back the House of Representatives in last week’s election, means that almost all legislation will grind to a halt. This is especially true in today’s era of political polarization. But there is one Democratic policy...
Read more
Aug 6, 2019 | Medicare Part D, News
Better health care was the top concern for 41 percent of voters in the midterm elections, but Congress does not have to wait until next year to pass bipartisan health legislation. Among the must-pass bills for the 2018 lame duck session should be legislation that...
Read more
Aug 6, 2019 | Medicare Part D, News
In the wide ideological gulf between Democrat and Republican healthcare reform efforts — with “Medicare For All” at one end and a market-based system at the other — there has emerged one bipartisan point of agreement: Those with preexisting conditions must...
Read more
